MarketOpen Trading Titan Podcast — Alterity Therapeutics (ASX: ATH) Granted New U.S. Composition of Matter Patent for ATH434 Everything in this podcast is for information purposes only. Nothing constitutes financial advice. Listeners must conduct their own research and consider their own financial circumstances before making any investment decision.